Pediatrix Medical Group Inc.
MD | NYSE
$25.77
-$0.16 (-0.62%)
At close: Sep 21, 2026, 4:00 PM ET
$25.77
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Market Data
Market Cap $2.13B
Enterprise Value $2.33B
Beta 0.65
Average Volume 829.09K
Shares Outstanding (Diluted) 81.41M
Shares Change YoY -6.27%
Institutional Ownership 100.00%
Exchange NYSE
ISIN US58502B1061
Price Performance
Price Change 1M -4.0%
Price Change 3M 8.0%
Price Change 6M 21.6%
Price Change YTD 21.0%
Price Change 1Y 55.6%
Price Change 3Y 108.2%
Price Change 5Y -10.7%
1M CAGR (ann.) -2.2%
1Y CAGR (ann.) 60.3%
5Y CAGR (ann.) -2.5%
All-Time CAGR 0.8%
Valuation
PE Ratio 12.33
Forward PE 10.14
PEG Ratio 0.19
Forward PEG 3.08
PS Ratio 1.08
Forward PS 1.10
PB Ratio 2.40
P/FCF Ratio 9.24
P/Adj. FCF Ratio 10.14
P/OCF Ratio 8.29
EV/Sales 1.20
EV/EBIT 9.56
EV/EBITDA 8.73
EV/FCF 10.19
Earnings Yield 8.1%
FCF Yield 10.8%
Adj. FCF Yield 9.9%
Financial Health
Net Debt $180.05M
Total Debt $619.96M
Cash & Short-Term Investments $404.2M
Total Assets $2.13B
Current Ratio 1.32
Quick Ratio 1.32
Debt / Equity Ratio 0.70
Debt / EBITDA 2.32
Debt / FCF 2.71
OCF / Debt 0.40
Interest Coverage 8.01
Altman Z-Score 2.40
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 25.9%
Operating Profit Margin 11.6%
EBITDA Margin 13.7%
Net Profit Margin 9.0%
FCF Margin 11.7%
Adj. FCF Margin 10.7%
SBC / Revenue 1.0%
SBC Impact (per share) -8.8%
Returns
Return on Assets 8.2%
Return on Equity 19.9%
Return on Invested Capital 9.6%
Return on Capital Employed 13.9%
Return on Tangible Assets 20.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -0.8%
Revenue CAGR 5Y 1.6%
Revenue CAGR 10Y -4.2%
EPS CAGR 3Y 19.0%
EPS CAGR 5Y 44.1%
EPS CAGR 10Y -5.2%
FCF CAGR 3Y 18.1%
FCF CAGR 5Y 17.4%
FCF CAGR 10Y -4.4%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 33
EPS Growth Next 3Y 0.9%
Revenue Growth Next 3Y 4.6%
Earnings Date Nov 1, 2026
EPS Estimate (next Q) $0.63
EPS Growth Est (next Q) -6.0%
Revenue Est (next Q) $498.18M
Revenue Growth Est (next Q) 1.1%
Fair Value Estimates
Graham Number $22.84
Graham Upside -11.4%
Lynch Fair Value $52.25
Lynch Upside 102.8%
Price Target $26.60
Price Target Upside 3.2%
Cash Flow
Operating Cash Flow $247.21M
Free Cash Flow $228.96M
Adj. Free Cash Flow $208.73M
FCF Per Share $2.88
OCF Per Share $3.11
OCF/S Ratio 12.7%
Income Statement
Revenue $1.95B
Gross Profit $506.14M
Operating Income $226.23M
EBITDA $267.04M
Net Income $174.81M
EPS (Diluted) $2.09
Revenue / Employee $455.75K
Profit / Employee $40.84K
Employees 4,280
Add to Watchlist
Select watchlists to add or remove MD